This enduring activity will provide learners with the latest developments in immunotherapy for leukemia, lymphoma, and myeloma and how these developments can be incorporated into regimens to improve the outcome of patients with these diseases.
This activity provides evidence-based insights, with an emphasis on current gaps in sleep maintenance insomnia. You will learn about the current challenges associated with managing sleep maintenance insomnia and how to utilize currently available and emerging treatments for management, especially in your older and elderly patients.
For over a decade, sorafenib was the only systemic agent available for the treatment of advanced hepatocellular carcinoma. However, the past 2.5 years has added 6 additional agents. In this Clinical ForumSM, our multidisciplinary expert roundtable convenes to discuss their collaborative care strategies for first and subsequent line management of advanced hepatocellular carcinoma (HCC) using case-based scenarios.
In this interactive roundtable discussion, Charles, his doctor, and 2 other prominent clinical experts gather to deliberate over reimbursement issues surrounding the clinical use of PCSK9-Is and offer practical strategies to facilitate navigating the prior authorization and appeals process.
Chronic rhinosinusitis with nasal polyps (CRSwNP) is associated with significant morbidity and negatively impacts quality of life. The good news is that biologic therapies targeting type 2 inflammatory pathways provide additional treatment options for CRSwNP. However, clinicians not only need to accurately diagnose nasal polyps in patients but also recognize the role of the underlying pathology to incorporate biologic agents into treatment regimens when appropriate, as Dr. Joseph K. Han explains.
Most people recover from uncomplicated influenza, but influenza can cause complications that result in severe illness and death. Some patients are at higher risk of experiencing these complications. In this program, physicians specializing in family medicine, internal medicine, and emergency medicine discuss their clinical experience about managing patients who develop symptoms of influenza and are at high risk of complications. They also explain recent changes to national guidelines. A patient who developed symptoms of influenza and was at high risk of complications shares his experience with testing and treatment for influenza.
Join Dr. Sandborn in a virtual demonstration of a clinical decision support tool that assesses disease burden and predicts treatment response for patients with moderate-to-severe Crohn’s Disease.
Join Dr. Dubinsky in a virtual demonstration of a clinical decision support tool that assesses disease burden and predicts treatment response for patients with moderate-to-severe ulcerative colitis.